01181nam0 22002771i 450 UON0052448720240513103615.34720240513d1936 |0itac50 baitaIT|||| |||||ˆL'‰anello dei LowenskoldSelma Lagerloftraduzione dallo svedese di Sven SchalinMilanoF.lli Treves1936183 p.18 cm.Valore stimato, recupero pregressoIT-UONSI STUDI NORDICISVEDESE/0101ITMilanoUONL000005839.7372Letteratura svedese narrativa. 1900-194522LAGERLĂ–FSelmaUONV126608395704SCHALINSvenUONV295442730Fratelli TrevesUONV267512650ITSOL20260605RICASIBA - SISTEMA BIBLIOTECARIO DI ATENEO E ARCHIVIO STORICOUONSIUON00524487SIBA - SISTEMA BIBLIOTECARIO DI ATENEO E ARCHIVIO STORICOSI STUDI NORDSVEDESE 0101 SI 51160 5 0101 Valore stimato, recupero pregressoDeterioratoAnello dei Lowenskold4661373UNIOR04202nam 2200769Ia 450 991114902170332120251117115608.09786612358241978128235824912823582439780520939288052093928X9781597344500159734450810.1525/9780520939288(CKB)111090529079620(EBL)224570(OCoLC)808037855(SSID)ssj0000092615(PQKBManifestationID)11114332(PQKBTitleCode)TC0000092615(PQKBWorkID)10023398(PQKB)10348720(DE-B1597)518878(OCoLC)55538532(DE-B1597)9780520939288(Au-PeEL)EBL224570(CaPaEBR)ebr10057097(CaONFJC)MIL235824(Perlego)550830(MiAaPQ)EBC224570(EXLCZ)9911109052907962020031010d2004 uy 0engurnn#---|u||utxtrdacontentcrdamediacrrdacarrierThe $800 million pill the truth behind the cost of new drugs /Merrill Goozner1st ed.Berkeley University of California Press20041 online resource (304 pages)Description based upon print version of record.9780520246706 0520246705 9780520239456 0520239458 Includes bibliographical references and index.Front matter --Contents --Introduction --PART ONE. BIOHYPE --PART TWO. DIRECTED RESEARCH --PART THREE. BIG PHARMA --Notes --Bibliography --Acknowledgments --IndexWhy do life-saving prescription drugs cost so much? Drug companies insist that prices reflect the millions they invest in research and development. In this gripping exposĂ©, Merrill Goozner contends that American taxpayers are in fact footing the bill twice: once by supporting government-funded research and again by paying astronomically high prices for prescription drugs. Goozner demonstrates that almost all the important new drugs of the past quarter-century actually originated from research at taxpayer-funded universities and at the National Institutes of Health. He reports that once the innovative work is over, the pharmaceutical industry often steps in to reap the profit. Goozner shows how drug innovation is driven by dedicated scientists intent on finding cures for diseases, not by pharmaceutical firms whose bottom line often takes precedence over the advance of medicine. A university biochemist who spent twenty years searching for a single blood protein that later became the best-selling biotech drug in the world, a government employee who discovered the causes for dozens of crippling genetic disorders, and the Department of Energy-funded research that made the Human Genome Project possible--these engrossing accounts illustrate how medical breakthroughs actually take place. The00 Million Pill suggests ways that the government's role in testing new medicines could be expanded to eliminate the private sector waste driving up the cost of existing drugs. Pharmaceutical firms should be compelled to refocus their human and financial resources on true medical innovation, Goozner insists. This book is essential reading for everyone concerned about the politically charged topics of drug pricing, Medicare coverage, national health care, and the role of pharmaceutical companies in developing countries.Eight hundred million dollar pillPrescription pricingDrugsPricesPharmaceutical industryConsumer educationPrescription pricing.DrugsPrices.Pharmaceutical industry.Consumer education.338.4/3/61510973Goozner Merrill1950-MiAaPQMiAaPQMiAaPQBOOK9911149021703321UNINA